It has been shown to attenuate the activation of reactive microglia in a mouse model of sporadic AD caused by streptozotocin [123] and to improve cognitive function in APP/PS1 and SAMP8 mouse models of AD [124,125]. This evidence concerns the gene APP and Alzheimer disease.